Tranexamic Acid for the Latarjet Procedure.

Sports Surgery Clinic (SSC)

Status: Completed

Conditions: Anterior Shoulder Instability

Treatments: Drug: Saline; Drug: Tranexamic Acid

Study type: Interventional

Funder types: Other

Identifiers

NCT03458468

SSC-Latarjet-001

Details and patient eligibility

About

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure.

The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

Enrollment: 100 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Anterior shoulder instability, warranting the Latarjet procedure

Exclusion criteria

• Patients with known risk factors for hyper-coagulable state
• Patients under 16
• Patients unable to give consent to partake in the trial

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

100 participants in 2 patient groups, including a placebo group

Group A

Experimental group

Description:

Tranexamic Acid 1g IV

Treatment:

Drug: Tranexamic Acid

Group B

Placebo Comparator group

Description:

Saline injection

Treatment:

Drug: Saline